LONDON (Reuters) - AstraZeneca said on Thursday it had struck four research collaborations in the hot area of genome editing as it bets on a new technology to deliver better and more precise drugs for a range of diseases.
via Reuters: Health News Read More Here..
No comments:
Post a Comment